Commercialization Rights

The latest news about Commercialization Rights: headlines, AI summaries and the full story from every source.

• Ocugen Outlicenses Gene Therapy Candidate OCU400 to Celairis Therapeutics for Asia-Pacific Region Seeking Alpha · November 10, 2026, 16:02 UTC
• Teva Pharmaceutical Acquires U.S. Commercialization Rights for Samsung Bioepis Biosimilars Seeking Alpha · November 3, 2026, 14:16 UTC